Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 5/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 5/20 | 0.40 |
| ▸ | ACACB | O00763 | 12/20 | 0.39 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5147283 | 0.85 | CPB2 (0.39) | CPB2 | |
| SCHEMBL5795636 | 0.80 | CPB2 (0.39) | ACACBCPB2 | |
| SCHEMBL594580 | 0.78 | CPB2 (0.42) | CPB2 | |
| Hydrochloric Acid SCHEMBL11418503 | 0.77 | CPB2 (0.41) | CPB2 | |
| Hydrochloric Acid SCHEMBL1521823 | 0.77 | CPB2 (0.41) | CPB2 | |
| Hydrochloric Acid SCHEMBL3428343 | 0.76 | CPB2 (0.40) | CPB2 | |
| SCHEMBL16727751 | 0.75 | CPB2 (0.48) | CPB2 | |
| SCHEMBL7131533 | 0.75 | CPB2 (0.35) | CPB2 | |
| SCHEMBL4727798 | 0.73 | CYP1A2 (0.45) | CPB2 | |
| SCHEMBL4726518 | 0.73 | CYP1A2 (0.45) | CPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240066124-A1 | REDUCING VISCOSITY OF PHARMACEUTICAL FORMULATIONS | AMGEN INC. (US) | 2024-02-29 | — | — | US | disclosed |
| US-11813328-B2 | Methods for reducing the viscosity of liquid pharmaceutical formulations comprising therapeutic proteins | AMGEN INC. (US) | 2023-11-14 | — | — | US | disclosed |
| EP-3909611-B1 | REDUCING VISCOSITY OF PHARMACEUTICAL FORMULATIONS | AMGEN INC (US) | 2023-08-30 | — | — | EP | disclosed |
| EP-3909611-A1 | REDUCING VISCOSITY OF PHARMACEUTICAL FORMULATIONS | Amgen Inc. (US) | 2021-11-17 | — | — | EP | disclosed |
| EP-3209332-B1 | REDUCING VISCOSITY OF PHARMACEUTICAL FORMULATIONS | AMGEN INC (US) | 2021-05-26 | — | — | EP | disclosed |
| US-9980919-B2 | Preparation of pH-responsive nanoparticles and promoted delivery of anticancer drugs into deep tumor tissues and application thereof | NATIONAL TSING HUA UNIVERSITY (TW) | 2018-05-29 | — | — | US | disclosed |
| US-20170333559-A1 | REDUCING VISCOSITY OF PHARMACEUTICAL FORMULATIONS | AMGEN INC. (US) | 2017-11-23 | — | — | US | disclosed |
| EP-3209332-A1 | REDUCING VISCOSITY OF PHARMACEUTICAL FORMULATIONS | Amgen Inc. (US) | 2017-08-30 | — | — | EP | disclosed |
| US-20160367489-A1 | PREPARATION OF pH-RESPONSIVE NANOPARTICLES AND PROMOTED DELIVERY OF ANTICANCER DRUGS INTO DEEP TUMOR TISSUES AND APPLICATION THEREOF | NATIONAL TSING HUA UNIVERSITY (TW) | 2016-12-22 | — | — | US | disclosed |